Crescent Formulations Pvt. Ltd.
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- RABICENT capsule, hard 20 mg+150 mg
- RABICENT D tablet 20 mg+30 mg
- RABICENT L capsule, hard 20 mg+75 mg
- RABICENT tablet 20 mg
- M01 - Antiinflamatorios y antirreumáticos
- NAPRODOM tablet 250 mg+10 mg
- NAPRODOM tablet 500 mg+10 mg
- N02 - Analgésicos
- FREZE tablet 37.5 mg+325 mg
- GABACENT tablet 100 mg
- GABACENT tablet 300 mg
- N03 - Antiepilépticos
- DIVALEX OD prolonged-release tablet 1 g
- DIVALEX OD prolonged-release tablet 125 mg
- DIVALEX OD prolonged-release tablet 250 mg
- DIVALEX OD prolonged-release tablet 500 mg
- DIVALEX OD prolonged-release tablet 750 mg
- EPICENT tablet 100 mg
- VALPORATE CHRONO prolonged-release tablet 200 mg
- VALPORATE CHRONO prolonged-release tablet 300 mg
- VALPORATE CHRONO prolonged-release tablet 500 mg
- N04 - Antiparkinsonianos
- DYSKINIL tablet 2 mg
- N05 - Psicolépticos
- DON FORTE tablet 4 mg+2 mg
- DON LS tablet 2 mg+2 mg
- DON PLUS tablet 3 mg+2 mg
- N06 - Psicoanalépticos
- CEACT tablet 400 mg
- CEACT tablet 800 mg
- CITA S FORTE tablet 10 mg+0.5 mg
- CITA S PLUSE tablet 5 mg+0.25 mg
- CITA S tablet 10 mg
- CITA S tablet 20 mg
- CITA S tablet 5 mg
- ELATE tablet 25 mg
- ELATE tablet 50 mg
- ELATE tablet 75 mg
- FLUTOP DR tablet 90 mg
- FLUTOP LA prolonged-release tablet 10 mg
- FLUTOP LA prolonged-release tablet 20 mg
- FLUTOP LA prolonged-release tablet 40 mg
- ODEP tablet 10 mg
- ODEP tablet 25 mg
- ODEP tablet 50 mg
- V06 - Nutrientes generales
- KEFIVE PLUS capsule, hard